Fingerprint
Dive into the research topics of 'Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically